Literature DB >> 17124012

Dangerous deception--hiding the evidence of adverse drug effects.

Jerry Avorn1.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17124012     DOI： 10.1056/NEJMp068246

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  The value of observational cohort studies for cancer drugs.

Authors:  David R Spigel
Journal:  Biotechnol Healthc       Date:  2010

2.  Medicine. Moving toward transparency of clinical trials.

Authors:  Deborah A Zarin; Tony Tse
Journal:  Science       Date:  2008-03-07       Impact factor: 47.728

3.  The US Food and Drug Administration: a dysfunctional agency in need of major reforms.

Authors:  Steven E Nissen
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

4.  Interpersonal continuity: old and new perspectives.

Authors:  Barbara Starfield; John Horder
Journal:  Br J Gen Pract       Date:  2007-07       Impact factor: 5.386

5.  Preemption, tort reform, and pharmaceutical claims: Part two: Has the Food and Drug Administration shown it is solely responsible for the protection of patients? Can it do so? Will it do so?

Authors:  Russell G Thornton
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-01

6.  Weaponizing Hope: Sources of Hope, Unrealistic Optimism, and Denial.

Authors:  Marsha Michie; Megan Allyse; Katie A Stoll; Zubin Master
Journal:  Am J Bioeth       Date:  2018-09       Impact factor: 11.229

7.  Unbalanced reporting of benefits and harms in abstracts on rofecoxib.

Authors:  Anders W Jørgensen; Karsten Juhl Jørgensen; Peter C Gøtzsche
Journal:  Eur J Clin Pharmacol       Date:  2010-02-17       Impact factor: 2.953

Review 8.  Patient-controlled analgesia-related medication errors in the postoperative period: causes and prevention.

Authors:  Jeff R Schein; Rodney W Hicks; Winnie W Nelson; Vanja Sikirica; D John Doyle
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

9.  Why we need easy access to all data from all clinical trials and how to accomplish it.

Authors:  Peter C Gøtzsche
Journal:  Trials       Date:  2011-11-23       Impact factor: 2.279

10.  Aprotinin and classic wound drainage are unnecessary in total hip replacement - a prospective randomized trial.

Authors:  F Fleischmann; C Matuschek; K Orth; P A Gerber; R Mota; W T Knoefel; M Peiper; M Schick; M van Griensven; Edwin Bölke; W Fleischmann
Journal:  Eur J Med Res       Date:  2011-01-27       Impact factor: 2.175
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.